A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Clinical trial NCT03383458 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03383458
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-18
- Primary completion
- 2026-05-27
- Enrollment
- 545
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.